Phase II Study in Multiple Myeloma Combination of Lenalidomide-Elotuzumab - 101931

Spotlight
Video

Phase II Study in Multiple Myeloma Combination of Lenalidomide-Elotuzumab

ASHReport has 256 videos Subscribe Here

Loading........
Description: Robert Z. Orlowski, MD, from MD Anderson Cancer Center discusses the phase II study in multiple myeloma and the combination of Lenalidomide-Elotuzumab at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/15/18
Added : 1 month ago
Category : Multiple Myeloma



Recommended

Nothing found.

More From ASHReport

Nothing found.